Neural oscillations and brain stimulation in Alzheimer's disease

Z Jafari, BE Kolb, MH Mohajerani - Progress in neurobiology, 2020 - Elsevier
Aging is associated with alterations in cognitive processing and brain neurophysiology.
Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory …

M/EEG-based bio-markers to predict the MCI and Alzheimer's disease: a review from the ML perspective

S Yang, JMS Bornot, K Wong-Lin… - IEEE Transactions on …, 2019 - ieeexplore.ieee.org
This paper reviews the state-of-the-art neuromarkers development for the prognosis of
Alzheimer's disease (AD) and mild cognitive impairment (MCI). The first part of this paper is …

Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies

J Schumacher, JP Taylor, CA Hamilton… - Alzheimer's research & …, 2020 - Springer
Objectives To investigate using quantitative EEG the (1) differences between patients with
mild cognitive impairment with Lewy bodies (MCI-LB) and MCI with Alzheimer's disease …

[HTML][HTML] Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer's Disease …

M Lassi, C Fabbiani, S Mazzeo, R Burali, AA Vergani… - NeuroImage: Clinical, 2023 - Elsevier
Alzheimer's disease (AD) pathological changes may begin up to decades earlier than the
appearance of the first symptoms of cognitive decline. Subjective cognitive decline (SCD) …

The importance of the validation of M/EEG with current biomarkers in Alzheimer's disease

F Maestú, P Cuesta, O Hasan, A Fernandéz… - Frontiers in human …, 2019 - frontiersin.org
Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are
the analysis of cerebral spinal fluid (CSF) to detect levels of Aβ42 and phosphorylated-tau …

Alpha power and functional connectivity in cognitive decline: a systematic review and meta-analysis

N Lejko, DI Larabi, CS Herrmann… - Journal of …, 2020 - content.iospress.com
Background: Mild cognitive impairment (MCI) is a stage between expected age-related
cognitive decline and dementia. Dementias have been associated with changes in neural …

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol

S Mazzeo, M Lassi, S Padiglioni, AA Vergani… - BMC neurology, 2023 - Springer
Background As disease-modifying therapies (DMTs) for Alzheimer's disease (AD) are
becoming a reality, there is an urgent need to select cost-effective tools that can accurately …

Electroencephalography as a non-invasive biomarker of Alzheimer's disease: a forgotten candidate to substitute CSF molecules?

P Monllor, A Cervera-Ferri, MA Lloret, D Esteve… - International Journal of …, 2021 - mdpi.com
Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should
be objective and quantifiable and respond to specific therapeutic interventions. Optimal …

Insular and limbic abnormal functional connectivity in early-stage Parkinson's disease patients with autonomic dysfunction

M Conti, E Garasto, R Bovenzi, V Ferrari… - Cerebral …, 2024 - academic.oup.com
Autonomic symptoms in Parkinson's disease result from variable involvement of the central
and peripheral systems, but many aspects remain unclear. The analysis of functional …

Characterization of young and old adult brains: An EEG functional connectivity analysis

B Moezzi, LM Pratti, B Hordacre, L Graetz, C Berryman… - Neuroscience, 2019 - Elsevier
Brain connectivity studies have reported that functional networks change with older age. We
aim to (1) investigate whether electroencephalography (EEG) data can be used to …